Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 2
1(50.0%)
N/A
1(50.0%)
2Total
Phase 2(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT07402668Not ApplicableRecruiting

Does AI Make Clinicians More Appropriately Confident? A Randomized Study in Preterm Birth Prediction

Role: collaborator

NCT01359878Phase 2Completed

Fibrinogen Concentrate as Initial Treatment for Postpartum Haemorrhage: A Randomised Clinically Controlled Trial

Role: collaborator

NCT00209911Terminated

Study of the Effect of Cardioversion on Cardiac Volume in Patients With Persistent Atrial Fibrillation

Role: collaborator

All 3 trials loaded